Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000858 · ClinicalTrials.gov registry record

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections

A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
350
Enrollment target
3
Study locations

NCT00000858: Completed study of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT00000858 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 350 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (21% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000858, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
350 participants
Enrollment target
3
Study locations

Study Summary

To correlate HIV-1 viral load in vaginocervical secretions (VCS), as measured by culture and nucleic acid detection, with that found in peripheral blood and HIV clinical status. To determine whether systemic and local HIV specific antibody influences the quality and type of virus isolated from VCS. To ascertain whether the presence of specific infectious agents (e.g., HPV, HSV, CMV, etc.) influences the amount and type of virus isolated from VCS. Predictors for the development of the acquired immunodeficiency syndrome (AIDS) in HIV infected individuals have been studied primarily among adult males and in selected small populations. Although many of these predictors may be relevant to women, HIV infection does manifest itself differently between the sexes. Therefore, it is important to study the spectrum of HIV disease in women and to identify unique and common markers, cofactors, and predictors of disease progression.

Conditions Studied

HIV Infections

Study Locations (3)

California

  • Univ of California / San Francisco - San Francisco

District of Columbia

  • Georgetown Univ Med Ctr - Washington D.C.

New York

  • SUNY / Health Sciences Ctr at Brooklyn - Brooklyn

Trial Details

FieldValue
Enrollment Target 350 participants
National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

What the finished NCT00000858 record still lists

NCT00000858 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (21% lower).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00000858 reports a single indexed study location in California, District of Columbia, New York.

Frequently Asked Questions

What is clinical trial NCT00000858 about?

NCT00000858 is a clinical study titled "Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections". To correlate HIV-1 viral load in vaginocervical secretions (VCS), as measured by culture and nucleic acid detection, with that found in peripheral blood and HIV clinical status. To determine whether systemic and local HIV specific antibody influences the quality and type of virus isolated from VCS. ...

What is the current status of trial NCT00000858?

This trial is currently completed. The enrollment target is 350 participants.

What conditions does trial NCT00000858 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT00000858?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000858 being conducted?

This trial has 3 study locations across California, District of Columbia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00000858's enrollment target sits among peer trials

350 98th of 542 higher than 443 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Related registry views

Source: ClinicalTrials.gov NCT00000858, the US trial registry maintained by the National Library of Medicine. NCT00000858 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.